Global Retirement Partners LLC Increases Holdings in The Ensign Group, Inc. $ENSG

Global Retirement Partners LLC boosted its stake in shares of The Ensign Group, Inc. (NASDAQ:ENSG) by 286.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,888 shares of the company’s stock after buying an additional 4,364 shares during the period. Global Retirement Partners LLC’s holdings in The Ensign Group were worth $1,026,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of ENSG. Baillie Gifford & Co. raised its holdings in shares of The Ensign Group by 62.1% during the 4th quarter. Baillie Gifford & Co. now owns 4,569,254 shares of the company’s stock worth $795,964,000 after acquiring an additional 1,750,645 shares during the period. Wasatch Advisors LP grew its holdings in shares of The Ensign Group by 6.0% in the second quarter. Wasatch Advisors LP now owns 3,558,675 shares of the company’s stock valued at $548,961,000 after purchasing an additional 199,983 shares during the period. Capital Research Global Investors increased its position in The Ensign Group by 7.2% during the third quarter. Capital Research Global Investors now owns 2,016,101 shares of the company’s stock worth $348,322,000 after purchasing an additional 136,260 shares during the last quarter. Dimensional Fund Advisors LP increased its position in The Ensign Group by 0.8% during the third quarter. Dimensional Fund Advisors LP now owns 1,085,380 shares of the company’s stock worth $187,516,000 after purchasing an additional 8,272 shares during the last quarter. Finally, Franklin Resources Inc. raised its stake in The Ensign Group by 0.8% during the third quarter. Franklin Resources Inc. now owns 522,691 shares of the company’s stock worth $90,305,000 after purchasing an additional 4,206 shares during the period. 96.12% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ENSG has been the topic of several recent analyst reports. Weiss Ratings reiterated a “buy (b)” rating on shares of The Ensign Group in a report on Tuesday, April 21st. UBS Group set a $230.00 price target on shares of The Ensign Group and gave the company a “buy” rating in a research report on Friday, February 6th. Truist Financial set a $215.00 price objective on The Ensign Group and gave the company a “hold” rating in a report on Friday, February 6th. Zacks Research lowered shares of The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Finally, Wall Street Zen upgraded The Ensign Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, The Ensign Group presently has an average rating of “Moderate Buy” and an average price target of $216.75.

Insider Buying and Selling at The Ensign Group

In related news, Director John O. Agwunobi sold 392 shares of The Ensign Group stock in a transaction on Monday, April 20th. The stock was sold at an average price of $199.97, for a total value of $78,388.24. Following the completion of the transaction, the director directly owned 9,295 shares in the company, valued at approximately $1,858,721.15. This trade represents a 4.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction on Monday, May 4th. The stock was sold at an average price of $182.21, for a total value of $127,547.00. Following the transaction, the director directly owned 22,052 shares of the company’s stock, valued at $4,018,094.92. The trade was a 3.08% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 2,592 shares of company stock worth $512,364. Insiders own 4.00% of the company’s stock.

The Ensign Group Price Performance

Shares of ENSG opened at $171.94 on Tuesday. The company’s 50-day simple moving average is $191.44 and its 200-day simple moving average is $188.56. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.56 and a current ratio of 1.56. The Ensign Group, Inc. has a 1 year low of $134.79 and a 1 year high of $218.00. The stock has a market capitalization of $10.05 billion, a PE ratio of 28.00, a P/E/G ratio of 1.69 and a beta of 0.73.

The Ensign Group (NASDAQ:ENSG) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.85 earnings per share for the quarter, beating analysts’ consensus estimates of $1.79 by $0.06. The firm had revenue of $1.39 billion during the quarter, compared to analysts’ expectations of $1.40 billion. The Ensign Group had a net margin of 6.89% and a return on equity of 16.78%. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.52 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. Analysts forecast that The Ensign Group, Inc. will post 6.79 earnings per share for the current fiscal year.

The Ensign Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st were given a dividend of $0.065 per share. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.2%. The Ensign Group’s dividend payout ratio is currently 4.23%.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.